These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 31761116)
1. Highlights of Novel Vaccination Strategies in Allergen Immunotherapy. Komlósi ZI; Kovács N; Sokolowska M; van de Veen W; Akdis M; Akdis CA Immunol Allergy Clin North Am; 2020 Feb; 40(1):15-24. PubMed ID: 31761116 [TBL] [Abstract][Full Text] [Related]
4. Advances and highlights in allergen immunotherapy: On the way to sustained clinical and immunologic tolerance. Berings M; Karaaslan C; Altunbulakli C; Gevaert P; Akdis M; Bachert C; Akdis CA J Allergy Clin Immunol; 2017 Nov; 140(5):1250-1267. PubMed ID: 28941667 [TBL] [Abstract][Full Text] [Related]
12. Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future. Valenta R; Campana R; Focke-Tejkl M; Niederberger V J Allergy Clin Immunol; 2016 Feb; 137(2):351-7. PubMed ID: 26853127 [TBL] [Abstract][Full Text] [Related]
13. Recombinant allergy vaccines based on allergen-derived B cell epitopes. Valenta R; Campana R; Niederberger V Immunol Lett; 2017 Sep; 189():19-26. PubMed ID: 28472641 [TBL] [Abstract][Full Text] [Related]
14. Scientific foundations of allergen-specific immunotherapy for allergic disease. Soyka MB; van de Veen W; Holzmann D; Akdis M; Akdis CA Chest; 2014 Nov; 146(5):1347-1357. PubMed ID: 25367471 [TBL] [Abstract][Full Text] [Related]
15. Recombinant allergens for immunotherapy: state of the art. Zhernov Y; Curin M; Khaitov M; Karaulov A; Valenta R Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):402-414. PubMed ID: 31082821 [TBL] [Abstract][Full Text] [Related]